Recent trends in adolescent substance use, primary care screening, and updates in treatment options

Current Opinion in Pediatrics

Volumn 18, Issue 4, 2006, Pages 352-358

  Fournier, Mary E ^a   Levy, Sharon ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adolescents; Alcohol; Marijuana; Substance use; Tobacco

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACAMPROSATE; ALCOHOL; AMFEBUTAMONE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; COCAINE; DIAMORPHINE; DISULFIRAM; FLUNITRAZEPAM; HYDROCODONE BITARTRATE PLUS PARACETAMOL; KETAMINE; METHADONE; METHAMPHETAMINE; NALTREXONE; NICOTINE PATCH; OPIATE; OXYCODONE; PERCOCET;

ADOLESCENT; ALCOHOL CONSUMPTION; ALCOHOLISM; DETOXIFICATION; DRUG MECHANISM; FAMILY THERAPY; GROUP THERAPY; HEROIN DEPENDENCE; HOSPITALIZATION; HUMAN; MASS SCREENING; NICOTINE REPLACEMENT THERAPY; OPIATE ADDICTION; OUTPATIENT CARE; PATIENT COUNSELING; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ADOLESCENT; AMBULATORY CARE; BEHAVIOR, ADDICTIVE; COUNSELING; HUMANS; PRIMARY HEALTH CARE; SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33747477472     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000236381.33907.9d     Document Type: Review

References (41)

1. Greydanus DE. The adolescent and substance abuse: current concepts. Dis Mon 2005; 51:392-431. This excellent article provides a very detailed review of adolescent substance abuse.
2. Grunbaum JA, Kann L, Kinchen S. Centers for Disease Control and Prevention. United States: youth risk behavior surveillance, 2003. MMWR 53(SS02); 21 May 2004: 1-96.
3. Johnston LD, O'Malley PM, Backman JG, Schulenberg JE. Monitoring the future: national results on adolescent drug use, overview of key findings. Bethesda, MD: National Institute on Drug Abuse; 2004.
4. Holstege CP, Kell S, Baer AB, Fatovitch T, Prevalence of OxyContin abuse in high school students. J Toxicol Clin Toxicol 2002; 40:656 (abstract).
5. Kulig JW, Joffe A, Behnke M. American Academy of Pediatrics Clinical Report, tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics 2005; 115:816-821. This report from the American Academy of Pediatrics Committee on Substance Abuse provides clear and concise guidelines on the prevention of substance abuse in a pediatric office setting.
6. Wilson CR, Sherritt L, Gates E, et al. Are clinical impressions of adolescent substance use accurate? Pediatrics 2004; 114:e536-540.
7. Heyman RB, Adger H. Office Approach to Substance Abuse Prevention. Pediatr Clin North Am 1997; 44:1447-1455.
8. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984; 252:1905-1907.
9. Babor T, Ramon de la Fuente J, Saunders J, Grant M. The Alcohol Use Disorders Identification Test: guidelines for use in primary healthcare. WHO Publication No 894. Geneva: World Health Organization; 1989.
10. Cook RL, Chung T, Kelly TM, Clark DB. Alcohol Screening in young persons attending a sexually transmitted disease clinic: comparison of AUDIT, CRAFFT, and CAGE instruments. J Gen Intern Med 2005; 20:1-6. This is a good comparison of common screening tools and their effectiveness in adolescents.
11. Knight JR, Shrier LA, Bravender TD, et al. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med 1999; 153:591-596.
12. MacDonald D. Patterns of alcohol and drug use among adolescents. Pediatr Clin North Am 1987; 34:275-288.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association; 2000.
14. Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001; 96:1725-1742.
15. McCambridge J, Strang J. The efficacy of single session motivational interviewing in reducing drug consumption and perceptions of drug related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 2004; 99:39-52.
16. Carrol KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry 2005; 162:1452-1460. This is an excellent review of various psychological techniques for the treatment of substance abuse.
17. Waldron HB, Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction 2004; 99 (Suppl 2):93-105.
18. Corby EA, Roll JM, Ledgerwood DM, Schuster CR. Contingency management interventions for treating the substance abuse of adolescents: a feasibility study. Exp Clin Psychopharmacol 2000; 8:371-376.
19. Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentives: effects on drug use of methadone maintenance patients. J Consult Clin Psychol 1992; 60:927-934.
20. Liddle HA. Family-based therapies for adolescent alcohol and drug use: research contributions and future research needs. Addiction 2004; 99 (Suppl 2):76-92.
21. Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry 2002; 41:868-874.
22. Waldron HB, Slesnick N, Brody JL, et al. Treatment outcomes for adolescent substance abuse at 4 and 7 month assessments. J Consult Clinic Psychol 2001; 69:802-813.
23. Liddle HA, Dakof GA, Parker K, et al. Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse 2001; 27:651-688.
24. Diamond G, Godley SH, Liddle HA, et al. Five outpatient treatment models for adolescent marijuana use. Addiction 2002; 97:70-83.
25. McGovern MP, Carroll KM. Evidence-based practices for substance use disorders. Psychiatr Clin North Am 2003; 26:991-1010.
26. Gossop M, Harris J, Best D, et al. Is attendance at Alcoholics Anonymous meetings after inpatient treatment related to improved outcomes? A 6-month follow-up study. Alcohol Alcohol 2003; 38:421-426.
27. Kaminer Y, Blitz C, Burleson JA, et al. Measuring treatment process in cognitive behavioral and interactional group therapies for adolescent substance abusers. J Nervous Mental Dis 1998; 186:401-413.
28. Cornwall A, Blood L. Inpatient versus day treatment for substance abusing adolescents. J Nervous Mental Dis 1998; 186:482-580.
29. Pagnin D, de Queiruz V, Saggese EG. Predictors of attrition from day treatment of adolescents with substance-related disorders. Addictive Behav 2005; 30:1065-1069.
30. Mark TL, DiLonardo JD, Chalk M, Coffey RM. Trends in inpatient detoxification services. J Substance Abuse Treatment 2002; 23:253-260.
31. Hirshber D, Horgan A, Douglass D. Acute residential treatment: adapting our expertise for managed care. Germaine Lawrence; 1996. www.germainelawrence. org. http://germainelawrence.org/about/arta.html [Accessed 14 January 2006]
32. Hawthorne WB, Green EE, Lohr JB, et al. Comparison of outcomes of acute care in short-term residential treatment and psychiatric hospital setting. Psychiatr Serv 1999; 50:401-406.
33. Wychulis B. Residential treatment centers: the clinical perspective. Thomson Peterson's; 2005. www.petersons.com. http://www.petersons.com/common/ article.asp?id=1747&path=hs.fas.advice&sponsor=1 [Accessed 21 January 2006]
34. Wilderness programs and outdoor therapy. National Youth Network; 2006. www.nationalyouth.com. http://www.nationalyouth.com/wildernessandoutdoor.html [Accessed 21 January 2006]
35. Greydanus DE, Patel DR. Substance abuse in adolescents: a complex conundrum for the clinician. Pediatr Clin North Am 2003; 50:1179-1223.
36. Upadhyaya H, Deas D, Brady K. A practical clinical approach to the treatment of nicotine dependence in adolescents. J Am Acad Child Adolesc Psychiatry 2005; 44:942-946. This review provides clear guidelines for the treatment of tobacco use and nicotine addiction in adolescents.
37. Upadhyaya HP, Brady KT, Wang W. Buproprion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. J Am Acad Child Adolesc Psychiatry 2004; 43:199-205.
38. Sofuoglu M, Kosten TR. Pharmacologic management of relapse prevention in addictive disorder. Psychiatric Clin North Am 2004; 27:624-648.
39. Williams SH. Medications for treating alcohol dependence. Am Fam Physician 2005; 72:1775-1780. This is a very detailed review of available treatments for adolescents, although it is not specific for adolescents.
40. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. The Cochrane Library. Issue 3. Chichester: Johnson Wiley and Sons; 2004.
41. Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 43:1290-1297.